검색어 : 통합검색[649.1]
총 1,196건 중 1,000건 출력
, 3/100 페이지
-
21
- The rotational analysis of the <sup>1</sup>Π-X <sup loc='pre'>1</sup>Σ<sup>+</sup> system at 649.5 nanometers of zirconium oxide
- Balfour, Walter J.; ; (Journal of molecular spectroscopy, v.48, 1973, pp.313-321)
-
22
- lncRNA ZNF649-AS1 Induces Trastuzumab Resistance by Promoting ATG5 Expression and Autophagy
- Han, Mingli; Qian, Xueke; Cao, Hui; Wang, Fang; Li, Xiangke; Han, Na; Yang, Xue; Yang, Yunqing; Dou, Dongwei; Hu, Jianguo; Wang, Wei; Han, Jing; Zhang, Fan; Dong, Huaying; ; (Molecular therapy : the journal of the American Society of Gene Therapy, v.28, 2020, pp.2488-2502)
-
23
- 649 OX40/OX40L and 4-1BB/4-1BBL signaling in cutaneous anti-tumoral immunity
- Geidel, G.; Maurer, M.; Luger, T.; Loser, K.; ; (Journal of investigative dermatology, v.136, 2016, pp.S115)
-
24
- 649 Protein tyrosine kinase activity in 350 T1/T2, N0/N1 breast cancer. Preliminary results
- Bolla, M.; Rostaing-Puissant, B.; Bottari, S.P; Chedin, M.; Marron-Charriè re, J.; Colonna, M.; Berland, E.; Chambaz, E.M.; ; (European journal of cancer, v.31, 1995, pp.S136-S136)
-
25
- Malignancies associated with HIV-1 infection in children: One center's experience over 6 years. 649
- Desai, Ninad; Miller, Scott T.; Rao, Sreedhar P.; Handelsman, Edward; Fikrig, Senih; Cheah, Marc S.C.; Anderson, Virginia; Mendez, Hermann; ; (Pediatric research, v.41, 1997, pp.111-111)
-
26
- Expression of Vps1 I649K, a self-assembly defective yeast dynamin, leads to formation of extended endocytic invaginations
- Mishra Ritu; Smaczynska-de Rooij Iwona I.; Goldberg Martin W.; Ayscough Kathryn R.; ; (Communicative & Integrative Biology, v.4, 2011, pp.115-117)
-
27
- Subcutaneous VIS649, an APRIL-Neutralizing Antibody: Preliminary Pharmacokinetic (PK) and Pharmacodynamic (PD) Results of VIS649-102, a Phase 1, Single Ascending Dose Study in Healthy Volunteers : PO2024
- Zhang, Xiaoyan; Wang, Yanlin; Yarbrough, Jill; Schachter, Asher D.; Sloan, Susan E.; Otsuka Pharmaceutical Development and Commercialization Inc, Princeton, NJ; ; Otsuka Pharmaceutical Development and Commercialization Inc, Princeton, NJ; ; Visterra, Inc., Waltham, MA.; Visterra, Inc., Waltham, MA.; Visterra, Inc., Waltham, MA.; (Journal of the American Society of Nephrology : JASN, v.32, 2021, pp.621-622)
-
28
- Abstract 649: Mirk/dyrk1B kinase inactivation increases gemcitabine efficacy towards quiescent pancreatic cancer cells
- Ewton, Daina Z.; Vilenchik, Maria; Polonskaia, Ann; Hoffman, Ann; Zipf, Karen; Boylan, John F.; Heimbrook, Dave; Hu, Jing; Friedman, Eileen A.; ; (Cancer research : the official organ of the American Association for Cancer Research, Inc, v.71, 2011, pp.649-649)
-
29
- Energy Expenditure with Two Suspension Training Protocols: 649 June 1, 2: 00 PM - 2: 15 PM
- Nunez, Tony P.; Beltz, Nicholas M.; McLain, Trisha A.; Mermier, Christine M.; Kravitz, Len; University of New Mexcio, Albuquerque, NM. (Sponsor: Dr. Ann Gibson, FACSM); (Medicine and science in sports and exercise, v.48, 2016, pp.169-170)
-
30
- Abstract 649: AT1R Blockade With Losartan Attenuates Abdominal Aortic Aneurysm Development in Spontaneously Hypertensive Mice
- Ward, Nicholas D; Grespin, Tyler; Couch, Christine; Mukherjee, Rupak; Jones, Jeffrey; Ruddy, Jean Marie; Med Univ of South Carolina, Charleston, SC; Med Univ of South Carolina, Charleston, SC; Med Univ of South Carolina, Charleston, SC; Med Univ of South Carolina, Charleston, SC; Med Univ of South Carolina, Charleston, SC; Med Univ of South Carolina, Charleston, SC; (Arteriosclerosis, thrombosis, and vascular biology, v.39, 2019, )
QUICK MENU
